| 3P Learning Limited (3PL) ORDINARY FULLY PAID |
Consumer Discretionary |
$64 |
Change of Director's Interest Notice M Sandblom
|
30 Mar 2026 10:21AM |
$0.270 |
$0.235 |
fallen by
12.96%
|
|
| Xenitra Limited (XEN) ORDINARY FULLY PAID |
Consumer Discretionary |
$12 |
$30m Danone - Rockcheck Strategic Partnership
|
30 Mar 2026 10:20AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
XEN - Price-sensitive ASX Announcement
Full Release
Key Points
- $30m sales target for Danone products with Rockcheck
- Agreement duration from 1 May 2026 to 30 April 2027
- Established Xenitra as an authorized supplier to Rockcheck
- Focus on expanding B2B sales channels
- Partnership is central to Xenitra’s China market strategy
- Potential to expand into new product lines
- Xenitra aims to accelerate value creation post-reorganization
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lithium Universe Limited (LU7) ORDINARY FULLY PAID |
Materials |
$13 |
Date of AGM and Closing Date for Directors Nominations
|
30 Mar 2026 10:15AM |
$0.008 |
$0.008 |
fallen by
0%
|
|
| TMK Energy Limited (TMK) ORDINARY FULLY PAID |
Energy |
$38 |
2026 Corporate Governance Statement
|
30 Mar 2026 10:07AM |
$0.160 |
$0.140 |
fallen by
12.50%
|
|
| Conneqt Health Limited (CQT) ORDINARY FULLY PAID |
Health Care |
$25 |
Pulse Recognised by AARP as a Best Blood Pressure Monitor
|
30 Mar 2026 10:06AM |
$0.033 |
$0.039 |
risen by
18.18%
|
|
| Ainsworth Game Technology Limited (AGI) ORDINARY FULLY PAID |
Consumer Discretionary |
$509 |
First Supplementary Bidder's Statement
|
30 Mar 2026 10:05AM |
$1.180 |
$1.510 |
risen by
27.97%
|
|
AGI - Price-sensitive ASX Announcement
Full Release
Key Points
- Kjerulf David Hastings Ainsworth initiates a takeover bid for 5.5% of AGI shares.
- The offer price is set at $1.30 per share.
- The offer is open for acceptance until 27 April 2026.
- Ainsworth's voting power in AGI is 8.24%.
- Relevant interest in 27,748,217 shares.
- ASIC granted relief for specific disclosure modifications.
- Supplementary statement supplements the original statement from 12 March 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AVA Risk Group Limited (AVA) ORDINARY FULLY PAID |
Information Technology |
$17 |
Extraordinary General Meeting Results of Meeting
|
30 Mar 2026 10:04AM |
$0.052 |
$0.059 |
risen by
13.46%
|
|
| Carma Limited (CMA) ORDINARY FULLY PAID |
Consumer Discretionary |
$99 |
Cleansing Notice under s708(5)(e) Corporations Act
|
30 Mar 2026 10:04AM |
$0.915 |
$0.720 |
fallen by
21.31%
|
|
| Washington H. Soul Pattinson and Co. Limited (SOL) ORDINARY FULLY PAID |
Financials |
$16,181 |
Change of registered office address
|
30 Mar 2026 10:03AM |
$40.000 |
$42.590 |
risen by
6.48%
|
|
| Pursuit Minerals Limited (PUR) ORDINARY FULLY PAID |
Materials |
$26 |
Notification regarding unquoted securities - PUR
|
30 Mar 2026 10:01AM |
$0.080 |
$0.100 |
risen by
25%
|
|
| Vintage Energy Ltd (VEN) ORDINARY FULLY PAID |
Energy |
$7 |
Entitlement Offer opens and documents despatched
|
30 Mar 2026 10:00AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,821 |
Change of Director's Interest Notice - HK
|
30 Mar 2026 10:00AM |
$3.940 |
$4.450 |
risen by
12.94%
|
|
| Alterity Therapeutics Limited (ATH) ORDINARY FULLY PAID |
Health Care |
$109 |
Alterity Receives Positive FDA Feedback From Type C Meeting
|
30 Mar 2026 9:57AM |
$0.008 |
$0.010 |
risen by
25%
|
|
ATH - Price-sensitive ASX Announcement
Full Release
Key Points
- Alterity Therapeutics received positive FDA feedback after a Type C Meeting.
- The meeting focused on the Phase 3 development program for ATH434 in Multiple System Atrophy (MSA).
- Alignment was reached on key clinical pharmacology and non-clinical development elements.
- Future discussions with FDA will involve Chemistry, Manufacturing, and Controls (CMC) and Phase 3 trial design.
- The End-of-Phase 2 meeting is scheduled for mid-2026.
- ATH434 has shown efficacy in Phase 2 trials for MSA.
- Alterity Therapeutics is based in Melbourne, Australia, and San Francisco, USA.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pursuit Minerals Limited (PUR) ORDINARY FULLY PAID |
Materials |
$26 |
Notification regarding unquoted securities - PUR
|
30 Mar 2026 9:57AM |
$0.080 |
$0.100 |
risen by
25%
|
|
| Carma Limited (CMA) ORDINARY FULLY PAID |
Consumer Discretionary |
$99 |
Application for quotation of securities - CMA
|
30 Mar 2026 9:57AM |
$0.915 |
$0.720 |
fallen by
21.31%
|
|
| Blue Star Helium Limited (BNL) ORDINARY FULLY PAID |
Energy |
$38 |
Proposed issue of securities - BNL
|
30 Mar 2026 9:57AM |
$0.009 |
$0.007 |
fallen by
22.22%
|
|
| Argo Global Listed Infrastructure Limited (ALI) ORDINARY FULLY PAID |
Financials |
$445 |
App 3Y Change of Director's Interests - FA Hele
|
30 Mar 2026 9:56AM |
$2.380 |
$2.500 |
risen by
5.04%
|
|
| Pursuit Minerals Limited (PUR) ORDINARY FULLY PAID |
Materials |
$26 |
Section 708A Cleansing Notice
|
30 Mar 2026 9:56AM |
$0.080 |
$0.100 |
risen by
25%
|
|
| Blue Star Helium Limited (BNL) ORDINARY FULLY PAID |
Energy |
$38 |
Successful Placement Raising A$10.0 Million
|
30 Mar 2026 9:56AM |
$0.009 |
$0.007 |
fallen by
22.22%
|
|
BNL - Price-sensitive ASX Announcement
Full Release
Key Points
- Blue Star Helium Limited successfully raised A$10.0 million.
- The funds were raised through an institutional placement.
- A total of 1,666,666,667 new ordinary shares were issued at A$0.006 per share.
- The placement was oversubscribed and received strong support from various investors.
- The funds will be used for advancing the Galactica and Pegasus projects.
- The placement will be completed in two tranches.
- Settlement of Tranche 1 is expected on 7 April 2026.
- Shareholder approval for Tranche 2 is expected at the AGM in mid-May 2026.
- Canaccord Genuity (Australia) Limited and Blackpeak Capital Pty Ltd were involved as Lead Manager and Corporate Advisor respectively.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atomo Diagnostics Limited (AT1) ORDINARY FULLY PAID |
Health Care |
$21 |
Atomo Completes Capital Raise
|
30 Mar 2026 9:55AM |
$0.040 |
$0.023 |
fallen by
42.50%
|
|
AT1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Atomo to raise up to $4.0 million via placement and share purchase plan.
- Placement secured $3.0 million from institutional investors.
- Share Purchase Plan aims to raise up to $1.0 million.
- Funds to aid in commercializing diagnostic tests and operational scaling.
- Company funded through early 2028 with pro forma cash of $3.5 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aeris Resources Limited (AIS) ORDINARY FULLY PAID |
Materials |
$557 |
GOLDEN PLATEAU DRILL PROGRAM UPDATE
|
30 Mar 2026 9:54AM |
$0.395 |
$0.465 |
risen by
17.72%
|
|
AIS - Price-sensitive ASX Announcement
Full Release
Key Points
- Drill program expanded from 6,400m to 14,000m reflecting promising results.
- High-grade gold intersections reported in multiple lodes: Ferneyside, Sunnyside, South, and West lodes.
- Aeris Resources aims to expedite a Mineral Resource Estimate and economic assessment.
- Golden Plateau has historically produced approximately 850,000 gold ounces.
- The deposit is located 1km north of the Cracow Processing Facility.
- Encouraging drill results strengthen confidence in potential new ore source for Cracow.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| American Rare Earths Limited (ARR) ORDINARY FULLY PAID |
Materials |
$210 |
ARR commissions oxide to metal study for heavy rare earths
|
30 Mar 2026 9:53AM |
$0.320 |
$0.365 |
risen by
14.06%
|
|
| Steadfast Group Limited (SDF) ORDINARY FULLY PAID |
Financials |
$4,392 |
Appendix 3Y - Robert Kelly AM
|
30 Mar 2026 9:53AM |
$4.170 |
$3.950 |
fallen by
5.28%
|
|
| State Gas Limited (GAS) ORDINARY FULLY PAID |
Energy |
$8 |
Reinstatement to Quotation
|
30 Mar 2026 9:52AM |
$0.033 |
$0.020 |
fallen by
39.39%
|
|
GAS - Price-sensitive ASX Announcement
Full Release
Key Points
- Reinstatement of State Gas Limited to quotation.
- Suspension of State Gas Limited securities lifted following an announcement.
- State Gas Limited made an update on a proposed material asset sale.
- The company has a research and development grant claim.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Variscan Mines Limited (VAR) ORDINARY FULLY PAID |
Materials |
$7 |
Management and Board Changes
|
30 Mar 2026 9:52AM |
$0.006 |
$0.006 |
fallen by
0%
|
|
VAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Stewart Dickson resigns as Managing Director and CEO.
- Tom Kent transitions to executive director.
- San Jose Mine Restart Study completed.
- Stewart Dickson to act as CEO for up to six months.
- Executive search for new CEO initiated.
- Board thanks Stewart Dickson for his contributions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
